Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

Clinical trials and advanced MRI techniques with stem cell therapy for ischemic stroke: present and future perspectives

Liu J., Cheng L., Ma C., Wang X., Ji X., Li Y.

Clinical Trial on Stroke Research, published in J Transl Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
J Transl Med (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41063139
PMCID
PMC12505762
DOI
10.1186/s12967-025-07054-5
Citations
2

Abstract (original English)

Ischemic stroke remains a leading cause of disability and mortality worldwide. Currently, there are no effective therapeutic strategies to promote post-stroke nerve repair and regeneration in clinical practice. Stem cells, characterized by self-renewal and differentiation capabilities, offer insights into the treatment of stroke. Over the past few decades, stem cell therapy has yielded promising results in preclinical and clinical studies for the treatment of ischemic stroke. However, various challenges to the clinical application of stem cell therapy remain. Herein, we review clinical trials of stem cell therapy for different stages of ischemic stroke. Based on this summary, we discussed the issues that need to be considered in future clinical trials, including determining the optimal cell types and doses, ideal transplantation routes and timing, and appropriate assessment methods. Additionally, as neuroimaging plays an increasingly critical role in humans, we elaborate on the application of advanced magnetic resonance imaging (MRI) techniques in clinical trials. In terms of the future outlook, we discuss technological advances, introducing machine learning in the field of stroke, and using this approach for integrating multi-omics data. These results may provide information for further development of clinical trials in this field and promote the future application of stem cel

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansMagnetic Resonance ImagingStem Cell TransplantationClinical Trials as TopicStrokeIschemic Stroke

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research